Correlation between a new growth modulation index (GMI)-based Geistra score and efficacy outcomes in patients (PTS) with advanced soft tissue sarcomas (ASTS) treated with trabectedin (T): A Spanish group for research on sarcomas (GEIS-38 study).

被引：2
|
作者：
Martinez-Trufero, Javier
Hindi, Nadia
Cruz, Josefina
Alvarez, Rosa Maria Alvarez
Beveridge, Roberto Pedro Diaz
Morales, Claudia Maria Valverde
Gutierrez, Antonio
Bernad, Isabel Pajares
Lopez-Pousa, Antonio
Salgado, Maria Angeles Vaz
Lavernia, Javier
Cano, Juana Maria
Sevilla, Isabel
Rubio-Casadevall, Jordi
De Juan, Ana
Carrasco, Juan Antonio
Leon, Nieves Hernandez
Pujol, Carolina Agra
Lamana, Lucia Ferrando
Broto, Javier Martin
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.11070
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11070
引用
收藏
页数：6
相关论文
共 8 条
  • [1] A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study
    Martinez-Trufero, Javier
    Miguel De Sande-Gonzalez, Luis
    Luna, Pablo
    Martin-Broto, Javier
    Alvarez, Rosa
    Marquina, Gloria
    Diaz-Beveridge, Roberto
    Poveda, Andres
    Maria Cano, Juana
    Cruz-Jurado, Josefina
    Lopez Pousa, Antonio
    Vaz Salgado, Maria Angeles
    Valverde-Morales, Claudia M.
    Sevilla, Isabel
    Martinez-Garcia, Jeronimo
    Rubio-Casadevall, Jordi
    De Juan, Ana
    Antonio Carrasco, Juan
    Moura, David S.
    Gurruchaga-Sotes, Ibon
    Gutierrez, Antonio
    CANCERS, 2021, 13 (04) : 1 - 15
  • [2] Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study
    Martin-Liberal, Juan
    Lopez-Pousa, Antonio
    Martinez-Trufero, Javier
    Martin-Broto, Javier
    Cubedo, Ricardo
    Lavernia, Javier
    Redondo, Andres
    Antonio Lopez-Martin, Jose
    Mulet-Margalef, Nuria
    Sanjuan, Xavier
    Tirado, Oscar M.
    Garcia-del-Muro, Xavier
    TARGETED ONCOLOGY, 2018, 13 (01) : 81 - 87
  • [3] Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study
    Juan Martin-Liberal
    Antonio López-Pousa
    Javier Martínez-Trufero
    Javier Martín-Broto
    Ricardo Cubedo
    Javier Lavernia
    Andrés Redondo
    José Antonio López-Martín
    Nùria Mulet-Margalef
    Xavier Sanjuan
    Òscar M. Tirado
    Xavier Garcia-del-Muro
    Targeted Oncology, 2018, 13 : 81 - 87
  • [4] CUL4A and ERCC1 genesas predictive factors for trabectedin efficacy in advanced soft tissue sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) study.
    Broto, Javier Martin
    Fernandez-Serra, Antonio
    Lopez-Pousa, Antonio
    Gutierrez, Antonio
    De Las Penas, Ramon
    Martinez-Trufero, Javier
    Cruz, Josefina
    Alvarez, Rosa Maria
    Cubedo, Ricardo
    Redondo, Andres
    Carrasco, Juan Antonio
    Lopez-Martin, Jose A.
    Sala, Maria Angeles
    Sevilla, Isabel
    Balana, Carmen
    Salgado, Maria Angeles Vaz
    De Juan, Ana
    Poveda, Andres
    Hindi, Nadia
    Lopez-Guerrero, Jose Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study
    Moura, David S.
    Sanchez-Bustos, Paloma
    Fernandez-Serra, Antonio
    Lopez-Alvarez, Maria
    Mondaza-Hernandez, Jose L.
    Blanco-Alcaina, Elena
    Gavilan-Naranjo, Angela
    Martinez-Delgado, Paula
    Lacerenza, Serena
    Santos-Fernandez, Paloma
    Carrasco-Garcia, Irene
    Hidalgo-Rios, Samuel
    Gutierrez, Antonio
    Ramos, Rafael
    Hindi, Nadia
    Taron, Miguel
    Antonio Lopez-Guerrero, Jose
    Martin-Broto, Javier
    CANCERS, 2020, 12 (05)
  • [6] Phase II study of gemcitabine (GEM) plus sirolimus (SIR) in previously treated patients with advanced soft tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study.
    Garcia del Muro, Xavier
    Lopez-Pousa, Antonio
    Martinez-Trufero, Javier
    Martin Broto, Javier
    Cubedo, Ricardo
    Lavernia, Javier
    Redondo, Andres
    Lopez-Martin, Jose A.
    Mulet-Margalef, Nuria
    Sanjuan, Xavier
    Tirado, Oscar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Salvage surgical resection after high-dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS):: A potential positive selection bias -: A study of the Spanish Group for Research on Sarcomas (GEIS)
    Maurel, J
    Buesa, J
    López-Pousa, A
    Del Muro, XG
    Quintana, MJ
    Martín, J
    Casado, A
    Martínez-Trufero, J
    de las Peñas, R
    Balaña, C
    JOURNAL OF SURGICAL ONCOLOGY, 2004, 88 (01) : 44 - 49
  • [8] Randomized phase II trial of doxorubicin vs. trabectedin plus doxorubicin in first line treatment of patients with advanced non-resectable or metastatic soft tissue sarcomas: a Spanish Group for Sarcoma Research (GEIS) study
    Martin-Broto, J.
    Lopez-Pousa, A.
    Garcia del Muro, X.
    De Las Penas, R.
    Martinez-Trufero, J.
    Cruz, J.
    Alvarez, R.
    Cubedo, R.
    Redondo, A.
    Poveda, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S875 - S875
1